Baculoviral IAP repeat-containing protein
From Proteopedia
(Difference between revisions)
(Removing all content from page) |
|||
Line 1: | Line 1: | ||
+ | {{STRUCTURE_3han| PDB=3han | SIZE=400| SCENE= |right|CAPTION=Bacteriorhodopsin complex with retinal, [[3han]] }} | ||
+ | *'''Baculoviral IAP repeat-containing protein 1''' (BIRC1 or NAIP) inhibits the activities of caspase-3,7,9. BIRC1 acts as mediator of neuronal survival in pathological conditions and prevents motor-neuron apoptosis.<br /> | ||
+ | *'''Baculoviral IAP repeat-containing protein 2''' (cIAP1) and Baculoviral IAP repeat-containing protein 3 (cIAP2) inhibit apoptosis by interfering with the activation of caspase and by binding to TNFR-associated factors TRAF1 and TRAF2. cIAP1 is a multi-functional protein which acts as an E3 ubiquitin-protein ligase and plays a role in the modulation of the cell cycle. cIAP1 is involved in controlling b-cell survival under ER stress caused by lipotoxicity. Both cIAP1 and cIAP2 regulate NF-kB activation. cIAP2 inhibits apoptosis caused by serum deprivation but not by inducers of free radicals. cIAPs domains include 3 BIR (zinc-finger found in apoptosis inhibitors) domains, a UBA (Ubiquitin-Associated), CARD (Caspase Recruitment) and RING finger (zinc finger which contains Cys3-His-Cys4 motif) domain.<br /> | ||
+ | *For '''Baculoviral IAP repeat-containing protein 4''' see XIAP in [[Ubiquitin protein ligase]].<br /> | ||
+ | *'''Baculoviral IAP repeat-containing protein 6''' (BIRC6) inhibits caspase-3,7,9. Has a role in the final stages of cytokinesis, vescilcle targeting to the site of abscission and ubiquitin conjugation.<br /> | ||
+ | *'''Baculoviral IAP repeat-containing protein 7''' or melanoma inhibitor of apoptosis (ML-IAP) contains one BIR and one RING domain. ML-IAP has 2 isoforms. Isoform-a protects cells from staurosporine-induced apoptosis and isoform-b protects cells from etoposide-induced apoptpsis.<br /> | ||
+ | *'''Baculoviral IAP repeat-containing protein 8''' (BIRC8).<br /> | ||
+ | |||
+ | cIAP1 is a target for intervention against type 2 diabetes. Mutated or deleted BIRC1 were found in individuals with severe muscular atrophy. | ||
+ | |||
+ | == 3D Structures of Baculoviral IAP repeat-containing protein == | ||
+ | |||
+ | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
+ | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
+ | |||
+ | *Baculoviral IAP repeat-containing protein 1 (BIRC1) | ||
+ | |||
+ | **[[2vm5]] – hBIRC1 BIR2 domain – human<br /> | ||
+ | |||
+ | *Baculoviral IAP repeat-containing protein 2 (cIAP1) | ||
+ | |||
+ | **[[3m1d]] – hcIAP1 BIR1 domain <br /> | ||
+ | **[[1qbh]] – hcIAP1 BIR3 domain – NMR<br /> | ||
+ | **[[2l9m]] – hcIAP1 CARD domain – NMR<br /> | ||
+ | **[[3t6p]] – hcIAP1 BIR3-RING domain (mutant)<br /> | ||
+ | |||
+ | *cIAP1 complex | ||
+ | |||
+ | **[[3d9t]] – hcIAP1 BIR3 domain + caspase-9 peptide<br /> | ||
+ | **[[3d9u]] – hcIAP1 BIR3 domain + SMAC/DIABLO peptide<br /> | ||
+ | **[[3mup]], [[3oz1]], [[4eb9]] – hcIAP1 BIR3 domain + SMAC-mimetic<br /> | ||
+ | **[[3uw4]] – hcIAP1 BIR3 domain (mutant) + anti-cancer peptide<br /> | ||
+ | **[[4hy4]], [[4hy5]], [[4lge]], [[4lgu]], [[4mti]], [[4mu7]], [[4kmn]] – hcIAP1 BIR3 domain + inhibitor<br /> | ||
+ | |||
+ | *Baculoviral IAP repeat-containing protein 3 (cIAP2) | ||
+ | |||
+ | **[[3eb5]] – hcIAP2 RING domain<br /> | ||
+ | **[[2uvl]] – hcIAP2 BIR3 domain <br /> | ||
+ | |||
+ | *cIAP2 complex | ||
+ | |||
+ | **[[3eb6]] – hcIAP2 RING domain + ubiquitin-conjugating enzyme E2<br /> | ||
+ | **[[3m0d]] – hcIAP2 BIR1 domain + TNF-associated factor 1 + TNF-associated factor 2 <br /> | ||
+ | **[[3m0a]] – hcIAP2 BIR1 domain + TNF-associated factor 2 <br /> | ||
+ | |||
+ | *Baculoviral IAP repeat-containing protein 6 (BIRC6) | ||
+ | |||
+ | **[[3ceg]] – hBIRC6 UBA domain <br /> | ||
+ | |||
+ | *Baculoviral IAP repeat-containing protein 7 (ML-IAP) | ||
+ | |||
+ | **[[1oxn]], [[1oy7]] – hML-IAP BIR domain + peptide inhibitor<br /> | ||
+ | **[[1oxq]] – hML-IAP BIR domain + SMAC peptide inhibitor<br /> | ||
+ | **[[1tw6]], [[2i3h]] – hML-IAP/XIAP BIR domain (mutant) + SMAC peptide inhibitor<br /> | ||
+ | **[[2i3i]], [[3f7g]], [[3f7h]], [[3f7i]], [[3gt9]], [[3gta]] – hML-IAP/XIAP BIR domain (mutant) + peptidomimetic<br /> | ||
+ | **[[3uw5]] – hML-IAP/XIAP BIR domain (mutant) + anti-cancer peptidomimetic<br /> | ||
+ | **[[4auq]] – hML-IAP residues 239-298 + ubiquitin-conjugating enzyme E2 + ubiquitin<br /> | ||
+ | |||
+ | *Baculoviral IAP repeat-containing protein 8 (BIRC8) | ||
+ | |||
+ | **[[1xb0]], [[1xb1]] – hBIRC8 BIR domain + DIABLO | ||
+ | }} |
Revision as of 08:30, 23 July 2015
- Baculoviral IAP repeat-containing protein 1 (BIRC1 or NAIP) inhibits the activities of caspase-3,7,9. BIRC1 acts as mediator of neuronal survival in pathological conditions and prevents motor-neuron apoptosis.
- Baculoviral IAP repeat-containing protein 2 (cIAP1) and Baculoviral IAP repeat-containing protein 3 (cIAP2) inhibit apoptosis by interfering with the activation of caspase and by binding to TNFR-associated factors TRAF1 and TRAF2. cIAP1 is a multi-functional protein which acts as an E3 ubiquitin-protein ligase and plays a role in the modulation of the cell cycle. cIAP1 is involved in controlling b-cell survival under ER stress caused by lipotoxicity. Both cIAP1 and cIAP2 regulate NF-kB activation. cIAP2 inhibits apoptosis caused by serum deprivation but not by inducers of free radicals. cIAPs domains include 3 BIR (zinc-finger found in apoptosis inhibitors) domains, a UBA (Ubiquitin-Associated), CARD (Caspase Recruitment) and RING finger (zinc finger which contains Cys3-His-Cys4 motif) domain.
- For Baculoviral IAP repeat-containing protein 4 see XIAP in Ubiquitin protein ligase.
- Baculoviral IAP repeat-containing protein 6 (BIRC6) inhibits caspase-3,7,9. Has a role in the final stages of cytokinesis, vescilcle targeting to the site of abscission and ubiquitin conjugation.
- Baculoviral IAP repeat-containing protein 7 or melanoma inhibitor of apoptosis (ML-IAP) contains one BIR and one RING domain. ML-IAP has 2 isoforms. Isoform-a protects cells from staurosporine-induced apoptosis and isoform-b protects cells from etoposide-induced apoptpsis.
- Baculoviral IAP repeat-containing protein 8 (BIRC8).
cIAP1 is a target for intervention against type 2 diabetes. Mutated or deleted BIRC1 were found in individuals with severe muscular atrophy.
3D Structures of Baculoviral IAP repeat-containing protein
Updated on 23-July-2015